Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novavax reported $703.5M in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change
Adma Biologics ADMA:US USD 735M 110M
Agenus AGEN:US USD 505M 227M
AstraZeneca AZN:LN USD 174.08B 252.77M
BioCryst Pharmaceuticals BCRX:US USD 1.57B 568M
Dynavax Technologies DVAX:US USD 1.25B 105M
Geron GERN:US USD 1.1B 181M
GlaxoSmithKline GSK:LN GBP 58.52B 341.4M
MannKind MNKD:US USD 1.08B 304M
Merck & Co MRK:US USD 269.98B 11.32B
Minerva Neurosciences NERV:US USD 9M 0
Moderna Inc MRNA:US USD 59.23B 9.78B
Novartis NVS:US USD 208.53B 8.83B
Novavax NVAX:US USD 597M 277M
Peregrine Pharmaceuticals PPHM:US USD 858M 331M
Pfizer PFE:US USD 230.29B 57.33B
Sanofi SAN:FP EUR 126.39B 12.52B
Sarepta Therapeutics SRPT:US USD 12.84B 1.46B
TG Therapeutics TGTX:US USD 2.2B 482M